Chris Schiesl

Chris Schiesl is a seasoned finance professional with extensive experience in corporate financial planning and analysis. Currently serving as Senior Director of Corporate FP&A at Genmab since February 2021, Chris previously held key finance leadership roles at Sanofi, where responsibilities included managing the Allergy & Digestive Health Business Unit Finance and the Cardiovascular Business Unit Finance. Prior professional experiences include positions at Mylan Specialty, Novartis, and Tiffany & Co, where Chris excelled in business planning, analysis, and profitability reporting. Chris holds an MBA in Accounting from Montclair State University and a BS in Finance from Seton Hall University.